Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: C. K. Humphries who wrote (3685)	4/30/1998 8:24:00 AM
From: Craig Markell	Respond to of 7041

NDA.... Got your interest? My sources tell me that the NDA is due to be filed "any day now". You didn't think that the consistant rise in price was all due to Viagra... did you???? Nuff said. Craig

To: C. K. Humphries who wrote (3685)	4/30/1998 8:41:00 AM
From: Dauntless	Read Replies (1) \| Respond to of 7041

C. K. - happens all the time CIBA, at the time they licensed the drug to Zonagen, obviously thought they had bigger fish to fry. Happens all the time - Big pharma companies have more compounds than they could ever develop - prioritize and keep the ones they deem best for them - by licensing some of the rest they can get a better return on their research. The people at SGP got the chance to study the results of Phase I, II and III clinical trials - CIBA did not. Not necessarily smarter, just better informed. Same with the other three potential partners that negotiated for the distribution rights. Maybe they're all incapable of evaluating clinical data?